To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
The US-headquartered firm bought a portion of its stake in Delhi-based Dr Lal Pathlabs from previous investor Sequoia Capital.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Copyright PEI Media
Not for publication, email or dissemination